MGI Tech
Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates
Illumina said it plans to pursue a permanent injunction against BGI in the UK until the four patents expire — three in 2023 and one in 2027.
BGI Sues Illumina for Antitrust Violation, Claims Firm Obtained Sequencing Patents Through Fraud
In their complaint the plaintiffs claimed Illumina fraudulently obtained two US patents by concealing a reference from the patent office.
US Court Orders Illumina to Produce Inventors for Deposition in BGI Patent Lawsuit
BGI will have a chance to depose up to nine inventors of patents assigned to Illumina as part of a lawsuit over IP related to sequencing-by-synthesis chemistry.
Illumina Obtains Preliminary Injunction Against BGI
A US District Court will prevent BGI from distributing and promoting certain sequencing instruments that allegedly infringe Illumina patents.
USPTO Board Denies Illumina Request to Review BGI Patent
Illumina had argued that Complete Genomics' patent covering two-color sequencing-by-synthesis chemistry was obvious, but the US PTAB disagreed.